Clinical Trials List
Protocol NumberAC-201-PK-001
Not yet recruiting
2012-02-01 - 2012-05-01
Phase I
Terminated1
-
Trial Applicant
TWI BIOTECHNOLOGY, INC
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
0 participants
